JPWO2023032452A1 - - Google Patents
Info
- Publication number
- JPWO2023032452A1 JPWO2023032452A1 JP2023545119A JP2023545119A JPWO2023032452A1 JP WO2023032452 A1 JPWO2023032452 A1 JP WO2023032452A1 JP 2023545119 A JP2023545119 A JP 2023545119A JP 2023545119 A JP2023545119 A JP 2023545119A JP WO2023032452 A1 JPWO2023032452 A1 JP WO2023032452A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021140666 | 2021-08-31 | ||
PCT/JP2022/026235 WO2023032452A1 (en) | 2021-08-31 | 2022-06-30 | Test method for type-2 diabetes and colon cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2023032452A1 true JPWO2023032452A1 (en) | 2023-03-09 |
JPWO2023032452A5 JPWO2023032452A5 (en) | 2024-02-26 |
Family
ID=85412115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023545119A Pending JPWO2023032452A1 (en) | 2021-08-31 | 2022-06-30 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2023032452A1 (en) |
WO (1) | WO2023032452A1 (en) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120231970A1 (en) * | 2009-09-30 | 2012-09-13 | Japan Health Sciences Foundation | Colon cancer marker and method for testing for colon cancer |
DK3156505T3 (en) * | 2011-08-19 | 2019-08-26 | Hummingbird Diagnostics Gmbh | COMPLEX SET OF MIRNAs AS NON-INVASIVE BIOMARKERS FOR COLONANCES |
NO3051026T3 (en) * | 2011-10-21 | 2018-07-28 | ||
CN103555724B (en) * | 2013-10-24 | 2015-08-05 | 浙江理工大学 | The Serum miRNA biomarker of diabetes B and application thereof |
US10604810B2 (en) * | 2014-06-13 | 2020-03-31 | Toray Industries, Inc. | Colorectal cancer detection kit or device, and detection method |
CN112063714A (en) * | 2014-10-28 | 2020-12-11 | 广州复能基因有限公司 | miRNA related to colorectal cancer and application thereof |
EP3371323A1 (en) * | 2015-11-06 | 2018-09-12 | Medizinische Universität Innsbruck | MIcroRNA-122 IN METABOLIC DISEASES |
CN106148537B (en) * | 2016-08-08 | 2019-05-24 | 南京市妇幼保健院 | One kind serum relevant to diabetes B or blood plasma miRNA marker and its application |
CN106434872A (en) * | 2016-08-11 | 2017-02-22 | 河南大学 | MiRNA molecule marker hsa-miR-152-3p for diagnosing type 2 diabetes, and application thereof |
CN110791562A (en) * | 2019-12-09 | 2020-02-14 | 金华市中心医院 | miR-145-5P molecular marker for detecting type 2 diabetes mellitus, amplification primer and application thereof |
-
2022
- 2022-06-30 JP JP2023545119A patent/JPWO2023032452A1/ja active Pending
- 2022-06-30 WO PCT/JP2022/026235 patent/WO2023032452A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2023032452A1 (en) | 2023-03-09 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231113 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231113 |